Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Herpetic Eye Disease Study (HEDS) I
NCT00000138Phase 3Unknown
- Sponsor
- National Eye Institute
- Start
- May 1989
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
01
Overview
Phase 3, randomised, double-blind trial of prednisolone-21-phosphate and aciclovir in Herpes simplex stromal keratitis (HSSK) and iridocyclitis (6 arms), sponsored by National Eye Institute. Primary endpoint: Time to development of preset criteria for treatment failure at 16 weeks. Status: unknown.
02
Drugs
prednisolone-21-phosphateaciclovir
03
Conditions
Herpes simplex stromal keratitis (HSSK)iridocyclitis
Beyond the preview
Go deeper on NCT00000138.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00000138.